名媛直播

Ian Ingram

Ian Ingram

Authors >

Ian Ingram

Ian Ingram joined 名媛直播 in 2018 as Deputy Managing Editor, and covers oncology for the site. Ian Ingram has been a medical editor for the past decade. Prior to joining 名媛直播, he was managing editor of Cancer Network, directing the website鈥檚 news coverage and video production. Ian has also worked as a fact-checker, was an assistant editor at Narrative Magazine, and a manuscript reader at the Paris Review. He holds a B.A. in journalism from Purchase College. Ian lives in Connecticut, enjoys tennis, and almost always bowls a perfect game.

Connect:

email image

Latest from Ian Ingram

FDA APPROVED minocycline hydrochloride extended-release capsules (Emrosi) over a photo of a woman with rosacea on her cheeks

FDA Approves New Option for Rosacea

Antibiotic Emrosi topped doxycycline, placebo in phase III trials

FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.

FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population

A photo of the packaging and vial of Trodelvy.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy

FDA APPROVED dupilumab (Dupixent) over a computer rendering of a transparent body with the lung bronchi highlighted.

First-Ever Biologic Approved for COPD

Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations

FDA CRL tradipitant (Vanda) over a computer rendering of a stomach.

FDA Rejects NK1R Antagonist for Gastroparesis

Drugmaker none-too-pleased with agency's request for additional studies

FDA APPROVED benralizumab (Fasenra) over a photo of vasculitis rashes on a man鈥檚 leg and foot.

FDA OKs New Option for Rare Immune-Mediated Vasculitis

Benralizumab wins approval for eosinophilic granulomatosis with polyangiitis

FDA APPROVED ribociclib (Kisqali) over a computer rendering of breast cancer.

FDA Expands Approval of Ribociclib to Early Breast Cancer

Broad indication doubles the number of patients eligible for adjuvant CDK4/6 inhibition

FDA APPROVED Dupixent (dupilumab) over a medical illustration of nasal polyps.

First Drug OK'd for Chronic Rhinosinusitis With Nasal Polyps in Adolescents

Dupilumab lands expanded indication for upper airway disease

FDA APPROVED lebrikizumab (Ebglyss) over a photo of a woman with a severe atomic dermatitis rash on her face.

Lebrikizumab Wins FDA Approval for Eczema

38% of patients treated with IL-13 blocker achieved clear or almost-clear skin at 16 weeks

ERS over a photo of Messe Wien Exhibition Congress Center in Vienna, Austria.

ERS Roundup: Air Filtration Succeeds in Reducing Infections

Other studies looked at steroids for kids with pneumonia and a link between asthma and fertility

3

鈥�